Maria Cerrillo
Madrid, 28916, Spain
NCT Number: NCT02280798
Do differences in endometrial gene expression exist after different protocols of endometrial preparation for embryo transfer? The recent apparition of endometrial receptive arrays technology let us know if endometrial is receptive or not in patients with some problems of infertility as implantation failure, for that we want to know if this technology would tell us if the different kind of protocols for endometrial preparation origin differences that could explain some of the founded results.
Looking for future studies?
Notify Me18 year–34 year
Female
Observational
Madrid, 28916, Spain
Do differences in endometrial gene expression exist after different protocols of endometrial preparation for embryo transfer? The clinical results in different publications showed different results, some of them described the natural cycle superior as the substituted cycles, and in contrast other large series showed superior results in substituted cycles than natural but with an increased of pregnancies losses. The recent apparition of endometrial receptive arrays technology let us know if endometrial is receptive or not in patients with some problems of infertility as implantation failure, for that we want to know if this technology would tell us if the different kind of protocols for endometrial preparation origin differences that could explain some of the founded results.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 endometrial biopsy
Time frame: 4 months
Total RNA was extracted using the TRIzol method according to the manufacturer's recommendations (Life Technologies). Approximately 1-2 mg of total RNA was obtained per milligram of endometrial tissue. The RNA quality was assessed by loading 300 ng of total RNA onto an RNA LabChip and was analyzed in an A2100 Bioanalyzer (Agilent Technologies). Only samples with a RNA integrity number >7 were selected for microarray analysis.
Sample preparation and hybridization was adapted from the Agilent technical manual. Hybridized microarrays were scanned in an Axon 4100A scanner (Molecular Devices), and the data were extracted with the GenePix Pro 6.0 software (Molecular Devices). The ERA microarray validation has been previously published. Reverse transcriptase-polymerase chain reaction (PCR) was performed for four selected up-regulated genes: GPX3, FXYD2, SPP1, and MT1G.
The ERA gene expression values were preprocessed, normalized, and statistically analyzed. Briefly, the half background
Time frame: LH,E2,P4
Hormonal profile different dates of protocols
IVI Madrid
Other
Endometrial Gene Expression in Different Protocols of Endometrial Preparation
Acronym: ERA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07053995
Endometrial, Infection
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06707051
Abormal utèrine Bleeding, Agranulocytosis
Sahiwal, Punjab Province, Pakistan
View Trial DetailsNCT00026689
Brain, Breast
Bethesda, Maryland, United States
View Trial DetailsNCT07695077
Asymptomatic Post-menopause, Endometrial
View Trial Details